| Female (%) |
354 (44.9%) |
308 (45.8%) |
46 (39.3%) |
| Median Age |
62 |
61.5 |
67 |
| Immunosuppressed (%) |
117 (14.8%) |
0 (0%) |
117 (100%) |
| With Transplant (%) |
97 (12.3%) |
0 (0%) |
97 (82.9%) |
| On Immunosuppressive Meds (%) |
25 (3.17%) |
0 (0%) |
25 (21.4%) |
| MGH (%) |
389 (49.3%) |
366 (54.5%) |
23 (19.7%) |
| BWH (%) |
400 (50.7%) |
306 (45.5%) |
94 (80.3%) |
| Tests Ordered CSF IgM (%) |
204 (25.9%) |
184 (27.4%) |
20 (17.1%) |
| Tests Ordered CSF PCR (%) |
673 (85.3%) |
568 (84.5)% |
105 (89.7%) |
| Tests Ordered Serum IgM (%) |
53 (6.7%) |
45 (6.7%) |
8 (6.8)% |
| Tests Ordered Serum PCR (%) |
37 (4.7%) |
29 (4.3%) |
8 (6.8%) |
| Positive CSF IgM |
6 (2.9%) |
6 (3.3%) |
0 (0%) |
| Positive CSF_PCR |
1 (0.15%) |
1 (0.18%) |
0 (0%) |
| Positive Serum IgM |
3 (5.7%) |
3 (6.7%) |
0 (0%) |
| Positive_Serum PCR |
0 (0%) |
0 (0%) |
0 (0%) |